Cidara Therapeutics

Youtube Subscribe

Open: 0.7 Close: 0.7 Change: 0.0

The stock market through the eyes of an AI: Cidara Therapeutics.

Are looking for the most relevant information about Cidara Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Cidara Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cidara Therapeutics are: Cidara, Therapeutics, Dyadic, Cidar, Inc, International, trading, and the most common words in the summary are: therapeutic, inc, pharmaceutical, pharma, cidara, bioscience, biopharma, . One of the sentences in the summary was: to be replaced Home Investing Quotes Stocks United States CDTX Finanicals …

Concept Map

Semantic Network

Stock Summary

Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4..

Today's Summary

Dyadic International and Cidara Therapeutics are trading at a lower price-to-earning ratio. Dyadic has higher earnings, but lower revenue than Cidar Therapeutic. The stock has a beta of 0.93, indicating that its share price is less volatile. Cidara Therapeutics, Inc. - 8-K, Current Report 3 SEC Filings 06.12.23 Cidar, Melinta announce publication of Rezzayo data. Cidara Therapeutics, Inc. to be replaced Home Investing Quotes Stocks United States CDTX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker.

Today's News

Dyadic International and Cidara Therapeutics are trading at a lower price-to-earning ratio. Dyadic has higher earnings, but lower revenue than Cidar Therapeutic. The stock has a beta of 0.93, indicating that its share price is less volatile. Cidara Therapeutics, Inc. - 8-K, Current Report 3 SEC Filings 06.12.23 Cidar, Melinta announce publication of Rezzayo data. Cidara Therapeutics, Inc. to be replaced Home Investing Quotes Stocks United States CDTX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker.

Stock Profile

" Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4.67, implying a 253.79% upside from current levels. Cidara Therapeutics (CDTX) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.14 per share. Rezzayo (rezafungin) for the Treatment of Invasive Candidiasis in Adults received European approval for the treatment. Cidara Therapeutics, Inc. presents new data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023. Company announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)"

Keywords

This document will help you to evaluate Cidara Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cidara Therapeutics are: Cidara, Therapeutics, Dyadic, Cidar, Inc, International, trading, and the most common words in the summary are: therapeutic, inc, pharmaceutical, pharma, cidara, bioscience, biopharma, . One of the sentences in the summary was: to be replaced Home Investing Quotes Stocks United States CDTX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #inc #pharmaceutical #pharma #cidara #bioscience #biopharma.

Read more →

Youtube Subscribe

---